FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766983721> ?p ?o ?g. }

• W2766983721 abstract "Preventable drug-related hospital admissions can be associated with drugs used in diabetes and the benefits of strict diabetes control may not outweigh the risks, especially in older populations. The aim of this study was to look for evidence on risks and benefits of DPP-4 inhibitors in older adults and to use this evidence to develop recommendations for the electronic decision support tool of the PRIMA-eDS project.Systematic review using a staged approach which searches for systematic reviews and meta-analyses first, then individual studies only if prior searches were inconclusive. The target population were older people (≥65 years old) with type 2 diabetes. We included studies reporting on the efficacy and/or safety of DPP-4 inhibitors for the management of type 2 diabetes. Studies were included irrespective of DPP-4 inhibitors prescribed as monotherapy or in combination with any other drug for the treatment of type 2 diabetes. The target intervention was DPP-4 inhibitors compared to placebo, no treatment, other drugs to treat type 2 diabetes or a non-pharmacological intervention.Thirty studies (reported in 33 publications) were included: 1 meta-analysis, 17 intervention studies and 12 observational studies. Sixteen studies were focused on older adults and 14 studies reported subgroup analyses in participants ≥65, ≥70, or ≥75 years. Comorbidities were reported by 26 studies and frailty or functional status by one study. There were conflicting findings regarding the effectiveness of DPP-4 inhibitors in older adults. In general, DPP-4 inhibitors showed similar or better safety than placebo and other antidiabetic drugs. However, these safety data are mainly based on short-term outcomes like hypoglycaemia in studies with HbA1c control levels recommended for younger people. One recommendation was developed advising clinicians to reconsider the use of DPP-4 inhibitors for the management of type 2 diabetes in older adults with HbA1c <8.5% because of scarce data on clinically relevant benefits of their use. Twenty-two of the included studies were funded by pharmaceutical companies and authored or co-authored by employees of the sponsor.Other than the surrogate endpoint of improved glycaemic control, data on clinically relevant benefits of DPP-4 inhibitors in the treatment of type 2 diabetes mellitus in older adults is scarce. DPP-4 inhibitors might have a lower risk of hypoglycaemia compared to other antidiabetic drugs but data show conflicting findings for long-term benefits. Further studies are needed that evaluate the risks and benefits of DPP-4 inhibitors for the management of type 2 diabetes mellitus in older adults, using clinically relevant outcomes and including representative samples of older adults with information on their frailty status and comorbidities. Studies are also needed that are independent of pharmaceutical company involvement." @default.
• W2766983721 created "2017-11-10" @default.
• W2766983721 creator A5006930847 @default.
• W2766983721 creator A5014945911 @default.
• W2766983721 creator A5019239401 @default.
• W2766983721 creator A5021283346 @default.
• W2766983721 creator A5034168264 @default.
• W2766983721 creator A5049387477 @default.
• W2766983721 creator A5060484582 @default.
• W2766983721 creator A5072818795 @default.
• W2766983721 creator A5086644494 @default.
• W2766983721 date "2017-10-01" @default.
• W2766983721 modified "2023-10-14" @default.
• W2766983721 title "Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing" @default.
• W2766983721 cites W103558615 @default.
• W2766983721 cites W1601122071 @default.
• W2766983721 cites W1811061299 @default.
• W2766983721 cites W1856184110 @default.
• W2766983721 cites W1861672217 @default.
• W2766983721 cites W1866815316 @default.
• W2766983721 cites W1914121615 @default.
• W2766983721 cites W1965819590 @default.
• W2766983721 cites W1972565816 @default.
• W2766983721 cites W1982202068 @default.
• W2766983721 cites W1988358753 @default.
• W2766983721 cites W1996585036 @default.
• W2766983721 cites W1998735190 @default.
• W2766983721 cites W2002881577 @default.
• W2766983721 cites W2019286098 @default.
• W2766983721 cites W2019992226 @default.
• W2766983721 cites W2028317115 @default.
• W2766983721 cites W2029338738 @default.
• W2766983721 cites W2041927436 @default.
• W2766983721 cites W2043990618 @default.
• W2766983721 cites W2047844897 @default.
• W2766983721 cites W2062321935 @default.
• W2766983721 cites W2063362369 @default.
• W2766983721 cites W2064130493 @default.
• W2766983721 cites W2067736115 @default.
• W2766983721 cites W2073644162 @default.
• W2766983721 cites W2074925580 @default.
• W2766983721 cites W2083783651 @default.
• W2766983721 cites W2084744936 @default.
• W2766983721 cites W2093770528 @default.
• W2766983721 cites W2098292453 @default.
• W2766983721 cites W2102279107 @default.
• W2766983721 cites W2103828712 @default.
• W2766983721 cites W2105814725 @default.
• W2766983721 cites W2107462992 @default.
• W2766983721 cites W2107562831 @default.
• W2766983721 cites W2111069331 @default.
• W2766983721 cites W2113239598 @default.
• W2766983721 cites W2114437291 @default.
• W2766983721 cites W2117762041 @default.
• W2766983721 cites W2119790985 @default.
• W2766983721 cites W2125468958 @default.
• W2766983721 cites W2127854619 @default.
• W2766983721 cites W2128932694 @default.
• W2766983721 cites W2134236426 @default.
• W2766983721 cites W2134833483 @default.
• W2766983721 cites W2142830692 @default.
• W2766983721 cites W2144325462 @default.
• W2766983721 cites W2149971684 @default.
• W2766983721 cites W2151976861 @default.
• W2766983721 cites W2158506982 @default.
• W2766983721 cites W2165010366 @default.
• W2766983721 cites W2167084484 @default.
• W2766983721 cites W2171181570 @default.
• W2766983721 cites W2172193326 @default.
• W2766983721 cites W2229086209 @default.
• W2766983721 cites W2260648135 @default.
• W2766983721 cites W2315493661 @default.
• W2766983721 cites W2766324951 @default.
• W2766983721 cites W287950467 @default.
• W2766983721 cites W4230892627 @default.
• W2766983721 cites W4241931824 @default.
• W2766983721 cites W4299296695 @default.
• W2766983721 cites W652895649 @default.
• W2766983721 cites W67889411 @default.
• W2766983721 doi "https://doi.org/10.1186/s12877-017-0571-8" @default.
• W2766983721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5647559" @default.
• W2766983721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29047372" @default.
• W2766983721 hasPublicationYear "2017" @default.
• W2766983721 type Work @default.
• W2766983721 sameAs 2766983721 @default.
• W2766983721 citedByCount "34" @default.
• W2766983721 countsByYear W27669837212018 @default.
• W2766983721 countsByYear W27669837212019 @default.
• W2766983721 countsByYear W27669837212020 @default.
• W2766983721 countsByYear W27669837212021 @default.
• W2766983721 countsByYear W27669837212022 @default.
• W2766983721 countsByYear W27669837212023 @default.
• W2766983721 crossrefType "journal-article" @default.
• W2766983721 hasAuthorship W2766983721A5006930847 @default.
• W2766983721 hasAuthorship W2766983721A5014945911 @default.
• W2766983721 hasAuthorship W2766983721A5019239401 @default.
• W2766983721 hasAuthorship W2766983721A5021283346 @default.
• W2766983721 hasAuthorship W2766983721A5034168264 @default.
• W2766983721 hasAuthorship W2766983721A5049387477 @default.
• W2766983721 hasAuthorship W2766983721A5060484582 @default.

• next